Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis
The systemic inflammatory syndrome concept is one of the foundations that stand at the basis of revolutionary modern and future therapies, based on the in-depth understanding of the delicate mechanisms that govern the collaboration between the systems and organs of the human body and, at the same ti...
Main Authors: | Daniel Octavian Costache, Oana Feroiu, Adelina Ghilencea, Mihaela Georgescu, Ana Căruntu, Constantin Căruntu, Sorin George Țiplica, Mariana Jinga, Raluca Simona Costache |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/9/5198 |
Similar Items
-
Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet—A Comprehensive Review
by: Daniel Octavian Costache, et al.
Published: (2024-02-01) -
The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
by: Georgios Kokolakis, et al.
Published: (2022-12-01) -
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study
by: Paolo Dapavo, et al.
Published: (2022-05-01) -
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα
by: Julia Tittes, et al.
Published: (2024-03-01) -
Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors
by: Yuta Koike, et al.
Published: (2020-05-01)